Our studies, showing both increased number of cells with Treg characteristic and increased expression of Foxp3 marker in T cells incubated in the presence of GA (Fig. 2d, Table 2), demonstrate that inducible Treg cells may contribute to the overall therapeutic effect of this immunomodulator in patients with multiple sclerosis. The gene discussed is FOXP3; the disease is multiple sclerosis.